Medscape Neurology and Neurosurgery Headlines Medscape Neurology and Neurosurgery Headlines RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

When Should a Pediatrician Suspect a Rare Disease? When Should a Pediatrician Suspect a Rare Disease?
Common symptoms expressed in an intense or complicated way, or the presence of many symptoms in the same patient, should raise suspicion of rare disease, said one clinician.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis
The U.S. FDA has declined to approve Viatris and Mapi Pharma ' s once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...Reuters Health Information (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Atogepant for Episodic Migraine Prevention: Phase 3 Data Atogepant for Episodic Migraine Prevention: Phase 3 Data
Results of the ELEVATE trial demonstrating the safety and efficacy of oral atogepant for the prevention of treatment-resistant episodic migraine prevention have now been published.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 8, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Most Disadvantaged Least Likely to Receive Thrombolysis Most Disadvantaged Least Likely to Receive Thrombolysis
Black, male, and older ischemic stroke patients are less likely than other populations to antithrombolytic therapy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 8, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Top Papers From the 2024 International Stroke Conference Top Papers From the 2024 International Stroke Conference
Neurologist Christoph Diener picks his top studies from the 2024 International Stroke Conference.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Prodromal Parkinson's and REM Sleep Behavior Disorder Prodromal Parkinson's and REM Sleep Behavior Disorder
Indu Subramanian speaks with REM sleep behavior disorder expert Ron Postuma about when RSD is prodromal Parkinsons ' s disease and new strategies to classify PD.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

The Power of Patient-Reported Outcomes Inhibited by Barriers The Power of Patient-Reported Outcomes Inhibited by Barriers
Patient-reported outcomes in multiple sclerosis matter but remain underused due to multiple barriers.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Prognostic Value of sNfL in MS Confirmed Prognostic Value of sNfL in MS Confirmed
ASCLEPIOS sub-studies show high sNfL levels at 3 and 12 months predictive of future CNS activity in patients with multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Signal of Benefit for Stem Cell Therapy in Progressive MS Signal of Benefit for Stem Cell Therapy in Progressive MS
At interim analysis, a stem cell extension study showed favorable clinical and biomarker effects for progressive MS.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

No Support for BTK Inhibitor in Phase 3 MS Trial No Support for BTK Inhibitor in Phase 3 MS Trial
The phase 3 MS trial of the BTK inhibitor evobrutinib was not superior to teriflunomide for any endpoint.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Sleep Apnea Hard on the Brain Sleep Apnea Hard on the Brain
Symptoms of sleep apneas are associated with a 50% increased risk for cognitive and memory problems, results from a large study showed.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Seizure Risk Nearly Double in Patients With MS Seizure Risk Nearly Double in Patients With MS
The risk for seizure is almost twofold higher in patients with multiple sclerosis than in those without MS and higher still among those taking an S1PR modulator.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Migraine a Forerunner of Multiple Sclerosis? Migraine a Forerunner of Multiple Sclerosis?
A common comorbidity in multiple sclerosis migraine is not part of the 3- to 5-year disease prodrome, new research suggested.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

More Positive Phase 2 Data for Zilebesiran in Hypertension More Positive Phase 2 Data for Zilebesiran in Hypertension
The investigational RNA interference therapeutic, zilebesiran, has shown positive top-line results in the KARDIA-2 phase 2 study in the treatment of hypertension.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 5, 2024 Category: Neurology Tags: Cardiology Source Type: news

' No Surprises' as Ozanimod Holds up in RMS Extension Trial'No Surprises' as Ozanimod Holds up in RMS Extension Trial
Nearly 70% of patients with relapsing forms of MS were relapse-free at 5 years, but hematologists disagree over where the drug fits in the treatment plan.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 5, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news